| Pramipexole |
EU/1/97/051/023 |
MIRAPEXIN, Prolonged release tablet, 2.1 (3.00), mg, Pack: 30 |
Boehringer Ingelheim International GmbH, Германия |
Boehringen Ingelheim Pharma GmbH & Co. KG, Germany |
114.06 |
22.81 |
136.87 |
4% |
4.56 |
118.62 |
23.72 |
142.34 |
16% |
18.25 |
136.87 |
27.37 |
164.24 |
|
НСР-1883/27.11.2013 |
12.12.2013 |
12.12.2013 |
Неактивен |
3057 |
| Pramipexole |
EU/1/97/051/017 |
MIRAPEXIN, Prolonged release tablet, 0.52 (0.75), mg, Pack: 30 |
Boehringer Ingelheim International GmbH, Германия |
Boehringen Ingelheim Pharma GmbH & Co. KG, Germany |
31.22 |
6.24 |
37.46 |
4% |
1.25 |
32.47 |
6.49 |
38.96 |
16% |
5 |
37.47 |
7.49 |
44.96 |
|
НСР-1883/27.11.2013 |
12.12.2013 |
12.12.2013 |
Неактивен |
3056 |
| Pramipexole |
EU/97/051/006 |
MIRAPEXIN, Tablet, 1, mg, Pack: 30 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH & Co.KG, Germany |
29.1 |
5.82 |
34.92 |
6% |
1.75 |
30.85 |
6.17 |
37.02 |
18% |
5.24 |
36.09 |
7.22 |
43.31 |
|
НСР-993/16.08.2013 |
04.09.2013 |
04.09.2013 |
Неактивен |
2051 |
| Pramipexole |
EU/97/051/004 |
MIRAPEXIN, Tablet, 0.25, mg, Pack: 30 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH & Co.KG, Germany |
9.58 |
1.92 |
11.5 |
7% |
0.67 |
10.25 |
2.05 |
12.3 |
20% |
1.92 |
12.17 |
2.43 |
14.6 |
|
НСР-992/16.08.2013 |
04.09.2013 |
04.09.2013 |
Неактивен |
3296 |
| Pramipexole |
EU/1/97/051/023 |
MIRAPEXIN, Prolonged release tablet, 2.1 (3.00), mg, Pack: 30 |
Boehringer Ingelheim International GmbH, Германия |
Boehringen Ingelheim Pharma GmbH & Co. KG, Germany |
201.84 |
40.37 |
242.21 |
4% |
8.07 |
209.91 |
41.98 |
251.89 |
16% |
25 |
234.91 |
46.98 |
281.89 |
|
КЦ-1441/05.03.2010 |
26.03.2010 |
26.03.2010 |
Неактивен |
3057 |
| Pramipexole |
EU/1/97/051/017 |
MIRAPEXIN, Prolonged release tablet, 0.52 (0.75), mg, Pack: 30 |
Boehringer Ingelheim International GmbH, Германия |
Boehringen Ingelheim Pharma GmbH & Co. KG, Germany |
50.46 |
10.09 |
60.55 |
4% |
2.02 |
52.48 |
10.5 |
62.98 |
16% |
8.07 |
60.55 |
12.11 |
72.66 |
|
КЦ-1441/05.03.2010 |
26.03.2010 |
26.03.2010 |
Неактивен |
3056 |
| Pramipexole |
EU/97/051/006 |
MIRAPEXIN, Tablet, 1, mg, Pack: 30 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH & Co.KG, Germany |
57.25 |
11.45 |
68.7 |
4% |
2.29 |
59.54 |
11.91 |
71.45 |
16% |
9.16 |
68.7 |
13.74 |
82.44 |
|
КЦ-304/28.11.2008 |
25.12.2008 |
25.12.2008 |
Неактивен |
2051 |
| Pramipexole |
EU/97/051/004 |
MIRAPEXIN, Tablet, 0.25, mg, Pack: 30 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH & Co.KG, Germany |
15.29 |
3.06 |
18.35 |
6% |
0.92 |
16.21 |
3.24 |
19.45 |
18% |
2.75 |
18.96 |
3.79 |
22.75 |
|
КЦ-304/28.11.2008 |
25.12.2008 |
25.12.2008 |
Неактивен |
3296 |
| Ramipril |
20110670 |
Mirapril, Capsule, hard, 10, mg, Pack: 30 |
Софарма АД, България |
Софарма АД, България |
5.69 |
1.14 |
6.83 |
7% |
0.4 |
6.09 |
1.22 |
7.31 |
20% |
1.14 |
7.23 |
1.45 |
8.68 |
|
НСР-2900/05.03.2014; НСР-9845/21.07.2016 |
02.09.2016 |
02.09.2016 |
Заличен |
2594 |
| Ramipril |
20110670 |
Mirapril, Capsule, hard, 10, mg, Pack: 30 |
Софарма АД, България |
Софарма АД, България |
5.69 |
1.14 |
6.83 |
7% |
0.4 |
6.09 |
1.22 |
7.31 |
20% |
1.14 |
7.23 |
1.45 |
8.68 |
|
НСР-2900/05.03.2014 |
20.03.2014 |
20.03.2014 |
Неактивен |
2594 |
| Ramipril |
20110669 |
Mirapril, Capsule, hard, 5, mg, Pack: 30 |
Софарма АД, България |
Софарма АД, България |
2.85 |
0.57 |
3.42 |
7% |
0.2 |
3.05 |
0.61 |
3.66 |
20% |
0.57 |
3.62 |
0.72 |
4.34 |
|
НСР-2901/05.03.2014; НСР-9845/21.07.2016 |
02.09.2016 |
02.09.2016 |
Заличен |
2593 |
| Ramipril |
20110669 |
Mirapril, Capsule, hard, 5, mg, Pack: 30 |
Софарма АД, България |
Софарма АД, България |
2.85 |
0.57 |
3.42 |
7% |
0.2 |
3.05 |
0.61 |
3.66 |
20% |
0.57 |
3.62 |
0.72 |
4.34 |
|
НСР-2901/05.03.2014 |
20.03.2014 |
20.03.2014 |
Неактивен |
2593 |
| Ramipril |
20110670 |
Mirapril, Capsule, hard, 10, mg, Pack: 30 |
Софарма АД, България |
|
9.33 |
1.87 |
11.2 |
7% |
0.65 |
9.98 |
2 |
11.98 |
20% |
1.87 |
11.85 |
2.37 |
14.22 |
|
КЦРР-1603/05.11.2012 |
21.11.2012 |
21.11.2012 |
Неактивен |
2594 |
| Ramipril |
20110669 |
Mirapril, Capsule, hard, 5, mg, Pack: 30 |
Софарма АД, България |
|
4.85 |
0.97 |
5.82 |
7% |
0.34 |
5.19 |
1.04 |
6.23 |
20% |
0.97 |
6.16 |
1.23 |
7.39 |
|
КЦРР-1603/05.11.2012 |
21.11.2012 |
21.11.2012 |
Неактивен |
2593 |
| Methoxy polyethylene glycol-epoetin beta |
EU/1/07/400/010 |
Mircera, Solution for injection, 100 µg/0,3 ml, -, Pack: 1 pre-filled syringe |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG, Germany |
287.29 |
57.46 |
344.75 |
4% |
10 |
297.29 |
59.46 |
356.75 |
16% |
25 |
322.29 |
64.46 |
386.75 |
|
НСР-3304/24.04.2014; НСР-9707/07.07.2016 |
02.08.2016 |
02.08.2016 |
Активен |
2720 |
| Methoxy polyethylene glycol-epoetin beta |
EU/1/07/400/010 |
Mircera, Solution for injection, 100 µg/0,3 ml, -, Pack: 1 pre-filled syringe |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG, Germany |
287.31 |
57.46 |
344.77 |
4% |
10 |
297.31 |
59.46 |
356.77 |
16% |
25 |
322.31 |
64.46 |
386.77 |
|
НСР-3304/24.04.2014 |
08.05.2014 |
08.05.2014 |
Неактивен |
2720 |
| Methoxy polyethylene glycol-epoetin beta |
EU/1/07/400/009 |
Mircera, Solution for injection, 75 µg/0,3 ml, -, Pack: 1 pre-filled syringe |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG, Germany |
215.47 |
43.09 |
258.56 |
4% |
8.62 |
224.09 |
44.82 |
268.91 |
16% |
25 |
249.09 |
49.82 |
298.91 |
|
НСР-3305/24.04.2014; НСР-9708/07.07.2016 |
02.08.2016 |
02.08.2016 |
Активен |
2719 |
| Methoxy polyethylene glycol-epoetin beta |
EU/1/07/400/009 |
Mircera, Solution for injection, 75 µg/0,3 ml, -, Pack: 1 pre-filled syringe |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG, Germany |
215.49 |
43.1 |
258.59 |
4% |
8.62 |
224.11 |
44.82 |
268.93 |
16% |
25 |
249.11 |
49.82 |
298.93 |
|
НСР-3305/24.04.2014 |
08.05.2014 |
08.05.2014 |
Неактивен |
2719 |
| Methoxy polyethylene glycol-epoetin beta |
EU/1/07/400/011 |
Mircera, Solution for injection, 150 µg/0,3 ml, -, Pack: 1 pre-filled syringe |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG, Germany |
430.91 |
86.18 |
517.09 |
4% |
10 |
440.91 |
88.18 |
529.09 |
16% |
25 |
465.91 |
93.18 |
559.09 |
|
НСР-3302/24.04.2014; НСР-9709/07.07.2016 |
02.08.2016 |
02.08.2016 |
Активен |
2721 |
| Methoxy polyethylene glycol-epoetin beta |
EU/1/07/400/011 |
Mircera, Solution for injection, 150 µg/0,3 ml, -, Pack: 1 pre-filled syringe |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG, Germany |
430.95 |
86.19 |
517.14 |
4% |
10 |
440.95 |
88.19 |
529.14 |
16% |
25 |
465.95 |
93.19 |
559.14 |
|
НСР-3302/24.04.2014 |
08.05.2014 |
08.05.2014 |
Неактивен |
2721 |
| Methoxy polyethylene glycol-epoetin beta |
EU/1/07/400/008 |
Mircera, Solution for injection, 50 µg/0,3 ml, -, Pack: 1 pre-filled syringe |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG, Germany |
143.66 |
28.73 |
172.39 |
4% |
5.75 |
149.41 |
29.88 |
179.29 |
16% |
22.99 |
172.4 |
34.48 |
206.88 |
|
НСР-4286/05.08.2014 |
20.08.2014 |
20.08.2014 |
Активен |
3137 |
| Methoxy polyethylene glycol-epoetin beta |
EU/1/07/400/012 |
MIRCERA, Solution for injection, 200, mcg/ 0,3ml, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG, Germany |
574.6 |
114.92 |
689.52 |
4% |
10 |
584.6 |
116.92 |
701.52 |
16% |
25 |
609.6 |
121.92 |
731.52 |
цената се заличава с решение НСР-8587/24.03.2016 (в сила от 02.05.2016) |
НСР-3303/24.04.2014 |
08.05.2014 |
08.05.2014 |
Заличен |
2722 |
| Methoxy polyethylene glycol-epoetin beta |
EU/1/07/400/008 |
MIRCERA, Solution for injection, 50, mcg/ 0,3ml, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG, Germany |
156.96 |
31.39 |
188.35 |
4% |
6.28 |
163.24 |
32.65 |
195.89 |
16% |
25 |
188.24 |
37.65 |
225.89 |
|
НСР-1922/27.11.2013 |
19.12.2013 |
19.12.2013 |
Неактивен |
3137 |
| Methoxy polyethylene glycol-epoetin beta |
EU/1/07/400/011 |
MIRCERA, Solution for injection, 150, mcg/ 0,3ml, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG, Germany |
478.83 |
95.77 |
574.6 |
4% |
10 |
488.83 |
97.77 |
586.6 |
16% |
25 |
513.83 |
102.77 |
616.6 |
отхвърлена жалба от Комисия по прозрачност с решение КП-191/24.04.2013; промяна на обстоятелства НСР-1574/01.11.2013 |
КЦРР-1185/18.08.2012 |
04.09.2012 |
04.09.2012 |
Неактивен |
2721 |
| Methoxy polyethylene glycol-epoetin beta |
EU/1/07/400/012 |
MIRCERA, Solution for injection, 200, mcg/ 0,3ml, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG, Germany |
638.44 |
127.69 |
766.13 |
4% |
10 |
648.44 |
129.69 |
778.13 |
16% |
25 |
673.44 |
134.69 |
808.13 |
отхвърлена жалба от Комисия по прозрачност с решение КП-191/24.04.2013; промяна на обстоятелства НСР-1575/01.11.2013 |
КЦРР-1185/18.08.2012 |
04.09.2012 |
04.09.2012 |
Неактивен |
2722 |